These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27934638)

  • 1. Comparative Evaluation of Dehydroepiandrosterone Sulfate Potential to Predict Hepatic Organic Anion Transporting Polypeptide Transporter-Based Drug-Drug Interactions.
    Nishizawa K; Nakanishi T; Tamai I
    Drug Metab Dispos; 2017 Feb; 45(2):224-227. PubMed ID: 27934638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dehydroepiandrosterone sulfate, a useful endogenous probe for evaluation of drug-drug interaction on hepatic organic anion transporting polypeptide (OATP) in cynomolgus monkeys.
    Watanabe M; Watanabe T; Yabuki M; Tamai I
    Drug Metab Pharmacokinet; 2015 Apr; 30(2):198-204. PubMed ID: 25989893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Evaluation of Plasma Bile Acids, Dehydroepiandrosterone Sulfate, Hexadecanedioate, and Tetradecanedioate with Coproporphyrins I and III as Markers of OATP Inhibition in Healthy Subjects.
    Shen H; Chen W; Drexler DM; Mandlekar S; Holenarsipur VK; Shields EE; Langish R; Sidik K; Gan J; Humphreys WG; Marathe P; Lai Y
    Drug Metab Dispos; 2017 Aug; 45(8):908-919. PubMed ID: 28576766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pitavastatin as an in vivo probe for studying hepatic organic anion transporting polypeptide-mediated drug-drug interactions in cynomolgus monkeys.
    Takahashi T; Ohtsuka T; Yoshikawa T; Tatekawa I; Uno Y; Utoh M; Yamazaki H; Kume T
    Drug Metab Dispos; 2013 Oct; 41(10):1875-82. PubMed ID: 23929936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leveraging of Rifampicin-Dosed Cynomolgus Monkeys to Identify Bile Acid 3-O-Sulfate Conjugates as Potential Novel Biomarkers for Organic Anion-Transporting Polypeptides.
    Thakare R; Gao H; Kosa RE; Bi YA; Varma MVS; Cerny MA; Sharma R; Kuhn M; Huang B; Liu Y; Yu A; Walker GS; Niosi M; Tremaine L; Alnouti Y; Rodrigues AD
    Drug Metab Dispos; 2017 Jul; 45(7):721-733. PubMed ID: 28396527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver.
    Vavricka SR; Van Montfoort J; Ha HR; Meier PJ; Fattinger K
    Hepatology; 2002 Jul; 36(1):164-72. PubMed ID: 12085361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated approach of in vivo and in vitro evaluation of the involvement of hepatic uptake organic anion transporters in the drug disposition in rats using rifampicin as an inhibitor.
    Imaoka T; Mikkaichi T; Abe K; Hirouchi M; Okudaira N; Izumi T
    Drug Metab Dispos; 2013 Jul; 41(7):1442-9. PubMed ID: 23640987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cynomolgus monkey as a potential model to assess drug interactions involving hepatic organic anion transporting polypeptides: in vitro, in vivo, and in vitro-to-in vivo extrapolation.
    Shen H; Yang Z; Mintier G; Han YH; Chen C; Balimane P; Jemal M; Zhao W; Zhang R; Kallipatti S; Selvam S; Sukrutharaj S; Krishnamurthy P; Marathe P; Rodrigues AD
    J Pharmacol Exp Ther; 2013 Mar; 344(3):673-85. PubMed ID: 23297161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of Prediction Methods for Drug-Drug Interactions Based on the Construction of Physiologically Based Pharmacokinetic Models for Hepatic OATP Substrate Drugs and Endogenous Substrates].
    Yoshikado T
    Yakugaku Zasshi; 2023; 143(1):11-19. PubMed ID: 36596534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption.
    Shitara Y; Maeda K; Ikejiri K; Yoshida K; Horie T; Sugiyama Y
    Biopharm Drug Dispos; 2013 Jan; 34(1):45-78. PubMed ID: 23115084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organic anion-transporting polypeptides contribute to the hepatic uptake of berberine.
    Chen C; Wu ZT; Ma LL; Ni X; Lin YF; Wang L; Chen KP; Huang CG; Pan G
    Xenobiotica; 2015; 45(12):1138-46. PubMed ID: 26068524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cynomolgus monkeys for the identification of endogenous biomarkers for hepatic transporter inhibition and as a translatable model to predict pharmacokinetic interactions with statins in humans.
    Chu X; Shih SJ; Shaw R; Hentze H; Chan GH; Owens K; Wang S; Cai X; Newton D; Castro-Perez J; Salituro G; Palamanda J; Fernandis A; Ng CK; Liaw A; Savage MJ; Evers R
    Drug Metab Dispos; 2015 Jun; 43(6):851-63. PubMed ID: 25813937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Analyses of the Influence of Parameters Governing Rate-Determining Process of Hepatic Elimination of Drugs on the Magnitudes of Drug-Drug Interactions via Hepatic OATPs and CYP3A Using Physiologically Based Pharmacokinetic Models.
    Yoshikado T; Maeda K; Kusuhara H; Furihata KI; Sugiyama Y
    J Pharm Sci; 2017 Sep; 106(9):2739-2750. PubMed ID: 28495568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organic Anion-Transporting Polypeptide Genes Are Not Induced by the Pregnane X Receptor Activator Rifampin: Studies in Hepatocytes In Vitro and in Monkeys In Vivo.
    Niu C; Wang Y; Zhao X; Tep S; Murakami E; Subramanian R; Smith B; Lai Y
    Drug Metab Dispos; 2019 Dec; 47(12):1433-1442. PubMed ID: 31582395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of Human Intestinal and Hepatic Organic Anion Transporting Polypeptides: Where Is the Evidence for Its Relevance in Drug-Drug Interactions?
    Rodrigues AD; Lai Y; Shen H; Varma MVS; Rowland A; Oswald S
    Drug Metab Dispos; 2020 Mar; 48(3):205-216. PubMed ID: 31879282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transport Kinetics, Selective Inhibition, and Successful Prediction of In Vivo Inhibition of Rat Hepatic Organic Anion Transporting Polypeptides.
    Ishida K; Ullah M; Tóth B; Juhasz V; Unadkat JD
    Drug Metab Dispos; 2018 Sep; 46(9):1251-1258. PubMed ID: 29891589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transporter-Mediated Hepatic Uptake Plays an Important Role in the Pharmacokinetics and Drug-Drug Interactions of Montelukast.
    Varma MV; Kimoto E; Scialis R; Bi Y; Lin J; Eng H; Kalgutkar AS; El-Kattan AF; Rodrigues AD; Tremaine LM
    Clin Pharmacol Ther; 2017 Mar; 101(3):406-415. PubMed ID: 27648490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism.
    Lau YY; Okochi H; Huang Y; Benet LZ
    Drug Metab Dispos; 2006 Jul; 34(7):1175-81. PubMed ID: 16624870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of rosuvastatin as an organic anion transporting polypeptide (OATP) probe substrate: in vitro transport and in vivo disposition in cynomolgus monkeys.
    Shen H; Su H; Liu T; Yao M; Mintier G; Li L; Fancher RM; Iyer R; Marathe P; Lai Y; Rodrigues AD
    J Pharmacol Exp Ther; 2015 May; 353(2):380-91. PubMed ID: 25740896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Prediction of OATP-Mediated Disposition and Biliary Clearance Using Human Liver Chimeric Mice.
    Miyake T; Tsutsui H; Hirabayashi M; Tachibana T
    J Pharmacol Exp Ther; 2023 Nov; 387(2):135-149. PubMed ID: 37142442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.